Dr Nicholas Figueroa, MD - Medicare Diagnostic Radiology in Boynton Beach, FL

Dr Nicholas Figueroa, MD is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Boynton Beach, Florida. He went to University Of Florida College Of Medicine and graduated in 2013 and has 11 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Diagnostic Imaging Services Inc, Baptist Outpatient Services Inc, Mori Bean And Brooks Inc and his current practice location is 2815 S Seacrest Blvd, Boynton Beach, Florida. You can reach out to his office (for appointments etc.) via phone at (561) 737-7733.

Dr Nicholas Figueroa is licensed to practice in Florida (license number ME139859) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1457791295.

Contact Information

Dr Nicholas Figueroa, MD
2815 S Seacrest Blvd,
Boynton Beach, FL 33435-7969
(561) 737-7733
Not Available



Physician's Profile

Full NameDr Nicholas Figueroa
GenderMale
SpecialityDiagnostic Radiology
Experience11 Years
Location2815 S Seacrest Blvd, Boynton Beach, Florida
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Nicholas Figueroa attended and graduated from University Of Florida College Of Medicine in 2013
  NPI Data:
  • NPI Number: 1457791295
  • Provider Enumeration Date: 06/25/2013
  • Last Update Date: 07/22/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 0648502237
  • Enrollment ID: I20191031001581

Medical Identifiers

Medical identifiers for Dr Nicholas Figueroa such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457791295NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0202XRadiology - Diagnostic Radiology ME139859 (Florida)Secondary
2085R0204XRadiology - Vascular & Interventional Radiology ME139859 (Florida)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Bethesda Hospital IncBoynton beach, FLHospital
Cleveland Clinic Martin North HospitalStuart, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Diagnostic Imaging Services Inc579968906318
Baptist Outpatient Services Inc6002807385148
Mori Bean And Brooks Inc8820077878633

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Nicholas Figueroa allows following entities to bill medicare on his behalf.
Entity NameDiagnostic Imaging Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1255301354
PECOS PAC ID: 5799689063
Enrollment ID: O20031120000110

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more Medical News

› Verified 8 days ago

Entity NameRadiology Associates Of South Florida Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1699759183
PECOS PAC ID: 5799689659
Enrollment ID: O20031121000573

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more Medical News

› Verified 8 days ago

Entity NameBaptist Outpatient Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437127529
PECOS PAC ID: 6002807385
Enrollment ID: O20040527000618

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more Medical News

› Verified 8 days ago

Entity NameMori Bean And Brooks Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093782070
PECOS PAC ID: 8820077878
Enrollment ID: O20040714001317

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Nicholas Figueroa is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Nicholas Figueroa, MD
2815 S Seacrest Blvd,
Boynton Beach, FL 33435-7969

Ph: () -
Dr Nicholas Figueroa, MD
2815 S Seacrest Blvd,
Boynton Beach, FL 33435-7969

Ph: (561) 737-7733

News Archive

Effective treatment for CI can reduce school-related behavioral problems in children

For children with convergence insufficiency (CI)—who have difficulty focusing on objects close up—effective treatments can help to reduce problems at school, reports a study in the January issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Anchor Therapeutics collaborates with OMJPI to develop GPCR targeted therapeutic compounds

Anchor Therapeutics today announced that it has entered into a collaboration and license agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. with the goal of developing G protein coupled receptor (GPCR) targeted therapeutic compounds utilizing Anchor's proprietary pepducin technology.

Omthera commences dosing in pivotal Epanova Phase III EVOLVE trial in patients with very high triglycerides

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that the first patient has been dosed in its pivotal Phase III EVOLVE (EpanoVa fOr Lowering Very high triglyceridEs) trial for Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega-3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).

Hain Celestial Group announces acquisition of Belvedere International

The Hain Celestial Group, Inc., a leading organic and natural products company with operations in North America, Europe and India providing consumers with A Healthier Way of Life, today announced the acquisition of Belvedere International, Inc., a leader in health and beauty care products including the Live Clean brand with approximately 200 baby, body and hair care products as well as several mass market brands sold primarily in Canada and manufactured in a company facility in Mississauga, Ontario, Canada.

New 3D printed floating photocatalysts remove persistent pollutants in wastewater

Researchers from Universidad Politécnica de Madrid have obtained 3D printed floating photocatalysts to remove persistent pollutants in wastewater.

Read more News

› Verified 8 days ago


Radiology Doctors in Boynton Beach, FL

Alfred Sem, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435
Phone: 561-736-1200    Fax: 561-742-1919
Dr. David Dahlenburg, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 2815 S Seacrest Blvd, Boynton Beach, FL 33435
Phone: 561-737-7733    
Dr. Valerie D'aurora, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2815 S. Seacrest Blvd, Boynton Beach, FL 33435
Phone: 551-208-6680    
Carol Ann Vicinanza Adami, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435
Phone: 561-736-1200    Fax: 561-742-1919
Fred Tow, M.D.
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 8921 Raven Rock Ct, Boynton Beach, FL 33473
Phone: 941-356-2266    
Ariana Alvarez, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2815 S Seacrest Blvd, Attention Betsy Cox, Boynton Beach, FL 33435
Phone: 561-736-1200    Fax: 561-742-1919
Richard Edelstein, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 2815 S Seacrest Blvd, Attention: Betsy Cox, Boynton Beach, FL 33435
Phone: 561-736-1200    Fax: 561-742-1919

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.